Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 32382 | 109 | 31.8 | 78% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 897 | 10655 | CARDIOTROPHIN 1//JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY//HYPERTROPHY |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | FD LC MS MS METHOD | Author keyword | 18 | 89% | 7% | 8 |
| 2 | MYOTROPHIN | Author keyword | 11 | 60% | 11% | 12 |
| 3 | DAABD CL | Author keyword | 8 | 100% | 5% | 5 |
| 4 | V 1 PROTEIN | Author keyword | 8 | 100% | 5% | 5 |
| 5 | FLUOROGENIC DERIVATIZATION | Author keyword | 7 | 46% | 10% | 11 |
| 6 | DAABD CI | Author keyword | 3 | 100% | 3% | 3 |
| 7 | S MYOTROPHIN | Author keyword | 3 | 100% | 3% | 3 |
| 8 | MOL CARDIOL NB 50 | Address | 2 | 67% | 2% | 2 |
| 9 | FD LC MS | Author keyword | 1 | 100% | 2% | 2 |
| 10 | V 1 | Author keyword | 1 | 27% | 3% | 3 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | FD LC MS MS METHOD | 18 | 89% | 7% | 8 | Search FD+LC+MS+MS+METHOD | Search FD+LC+MS+MS+METHOD |
| 2 | MYOTROPHIN | 11 | 60% | 11% | 12 | Search MYOTROPHIN | Search MYOTROPHIN |
| 3 | DAABD CL | 8 | 100% | 5% | 5 | Search DAABD+CL | Search DAABD+CL |
| 4 | V 1 PROTEIN | 8 | 100% | 5% | 5 | Search V+1+PROTEIN | Search V+1+PROTEIN |
| 5 | FLUOROGENIC DERIVATIZATION | 7 | 46% | 10% | 11 | Search FLUOROGENIC+DERIVATIZATION | Search FLUOROGENIC+DERIVATIZATION |
| 6 | DAABD CI | 3 | 100% | 3% | 3 | Search DAABD+CI | Search DAABD+CI |
| 7 | S MYOTROPHIN | 3 | 100% | 3% | 3 | Search S+MYOTROPHIN | Search S+MYOTROPHIN |
| 8 | FD LC MS | 1 | 100% | 2% | 2 | Search FD+LC+MS | Search FD+LC+MS |
| 9 | V 1 | 1 | 27% | 3% | 3 | Search V+1 | Search V+1 |
| 10 | 2 1 3 BENZOXADIAZOLE | 1 | 50% | 1% | 1 | Search 2+1+3+BENZOXADIAZOLE | Search 2+1+3+BENZOXADIAZOLE |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CDC10 SWI6 MOTIF | 6 | 100% | 4% | 4 |
| 2 | FLUOROGENIC DERIVATIZATION | 4 | 56% | 5% | 5 |
| 3 | NEURONS EXPRESS | 2 | 36% | 5% | 5 |
| 4 | CAENORHABDITIS ELEGANS PROTEINS | 1 | 50% | 2% | 2 |
| 5 | MYOTROPHIN | 1 | 13% | 5% | 5 |
| 6 | MYOTUBE | 1 | 50% | 1% | 1 |
| 7 | S MYOTROPHIN | 1 | 50% | 1% | 1 |
| 8 | ALPHA CRYSTALLIN B | 0 | 33% | 1% | 1 |
| 9 | SOLUBLE FLUOROGENIC REAGENT | 0 | 33% | 1% | 1 |
| 10 | 2 D DIGE | 0 | 15% | 2% | 2 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Straightforward proteomic analysis reveals real dynamics of proteins in cells | 2014 | 0 | 23 | 70% |
| Towards clinical proteomics analysis | 2011 | 10 | 27 | 30% |
| Anchoring skeletal muscle development and disease: the role of ankyrin repeat domain containing proteins in muscle physiology | 2010 | 11 | 106 | 17% |
| C-elegans: an invaluable model organism for the proteomics studies of the cholesterol-mediated signaling pathway | 2006 | 7 | 87 | 9% |
| Recent progress in the development of derivatization reagents having a benzofurazan structure | 2008 | 13 | 77 | 9% |
| Protein database of Caenorhabditis elegans | 2003 | 5 | 18 | 17% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | MOL CARDIOL NB 50 | 2 | 67% | 1.8% | 2 |
| 2 | CHEM TECHNOL ANIM PROD | 1 | 18% | 2.8% | 3 |
| 3 | PROTE ANAL | 1 | 25% | 1.8% | 2 |
| 4 | CARDIAC BIOL | 0 | 25% | 0.9% | 1 |
| 5 | MOL CARDIOL FF10 | 0 | 25% | 0.9% | 1 |
| 6 | WORKING GRP PULM HYPERTENS | 0 | 25% | 0.9% | 1 |
| 7 | MOL PSYCHOPHARMACOL | 0 | 13% | 1.8% | 2 |
| 8 | AG SCI TECH | 0 | 17% | 0.9% | 1 |
| 9 | BIO GENET A | 0 | 100% | 0.9% | 1 |
| 10 | EACH PHARMACEUT SCI | 0 | 100% | 0.9% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000123497 | RIBOSOME FORMATION//CARDIAC GROWTH//WORKING RAT HEART PREPARATION |
| 2 | 0.0000100540 | MYOCARDIAL COLLAGEN CONCENTRATION//HYPERTROPHY REVERSAL//REGIONAL SYMPATHETIC ACTIVITY |
| 3 | 0.0000079237 | DETECTION ORIENTED DERIVATIZATION//ISOTOPE CODED DERIVATIZATION//DEUTERATED STEROIDS |
| 4 | 0.0000073859 | SYNGAP1//GENES COGNIT PROGRAMME//NEUROCIENCIAS LIM 27 |
| 5 | 0.0000073222 | CALUMENIN//BIOCHEM FUNCT PROTE//RETICULOCALBIN |
| 6 | 0.0000071639 | COFILIN//LIM KINASE//ADF COFILIN |
| 7 | 0.0000070880 | HYPERPROLINEMIA//HYPERPROLINEMIA TYPE II//SUPERIOR MESENTERIC FLOW |
| 8 | 0.0000068599 | CARDIAC MED SECT//NHLI CARDIAC MED//BIOMED SCI MOL PATHOL |
| 9 | 0.0000067869 | SAMPLE PREFRACTIONATION//PREFRACTIONATION//ALKALINE PROTEINS |
| 10 | 0.0000067353 | WINTERS HEART FAILURE//CARDIAC CACHEXIA//PL CACHEXIA |